Related Experiment Video
Updated: May 24, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
Increased circulating concentrations of bioactive PTH 1-84 in patients with heart failure
D Gruson1, T Lepoutre, S A Ahn
1Pôle de recherche en Endocrinologie, Diabète et Nutrition, Institut de Recherche Expérimentale et Clinique, Brussels, Belgium. damien.gruson@uclouvain.be
Insights
Circulating parathyroid hormone (PTH) 1-84 levels are elevated in heart failure (HF) patients. Higher PTH 1-84 levels correlate with HF severity and biomarkers indicating disease worsening.
Area of Science:
- Cardiology
- Endocrinology
- Biomarkers
Background:
- Parathyroid hormone (PTH) is linked to left ventricular hypertrophy.
- Elevated PTH levels are associated with poor prognosis in heart failure (HF) patients.
Purpose of the Study:
- To measure bioactive PTH 1-84 levels in HF patients using a third-generation assay.
- To assess the association between PTH 1-84 levels and HF disease severity.
- To determine the relationship between PTH 1-84 and HF worsening biomarkers.
Main Methods:
- PTH 1-84 concentrations were measured in 76 HF patients and 49 healthy volunteers.
- Circulating levels of Nt-proANP, BNP, Nt-proBNP, proBNP, and Big ET-1 were also quantified.
Main Results:
- HF patients exhibited significantly higher PTH 1-84 levels compared to controls.
- PTH 1-84 levels increased with New York Heart Association functional classes.
- PTH 1-84 concentrations showed significant correlations with Nt-proANP, BNP, Nt-proBNP, proBNP, and Big ET-1.
Conclusions:
- Bioactive PTH 1-84 levels are significantly elevated in HF patients.
- Circulating PTH concentrations are related to HF severity and established biomarkers of disease progression.
Background:
PTH is related to left ventricular hypertrophy and its circulating levels are associated with worse prognosis in patients with heart failure (HF). The objectives of our study were to measure the circulating levels of bioactive PTH 1-84 through third-generation assay in HF patients, to determine their association with the disease severity as well as their relation with recognized biomarkers of HF worsening and prognosis.
Methods:
PTH 1-84 concentrations were determined in 76 HF patients and in 49 healthy volunteers. Circulating levels of amino-terminal proatrial natriuretic peptide (Nt-proANP), B-type natriuretic peptide (BNP), Nt-proBNP, proBNP, and big endothelin-1 (Big ET-1) were also measured.
Results:
HF patients had in- creased PTH 1-84 levels in comparison to controls. A significant increase of the PTH 1-84 circulating concentrations was observed according to the New York Heart Association functional classes. PTH 1-84 circulating concentrations were also significantly correlated with Nt-proANP, BNP, Nt-proBNP, proBNP, and Big ET-1.
Conclusions:
PTH 1-84 circulating levels are significantly increased in HF patients in comparison to healthy individuals. Our study has also demonstrated that circulating concentrations of bioactive PTH are related to HF severity and well-established biomarkers of the worsening of the disease.
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Heart Failure II: Pathophysiology
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Pathophysiology of Heart Failure
Skeleton and Calcium Homeostasis
